Authors

  • Gulshan Ergasheva

DOI:

https://doi.org/10.71337/inlibrary.uz.science-research.98502

Keywords:

thyroid gland cytology FNAB thyroid nodules autoimmune thyroiditis tumors.

Abstract

Cytological diagnosis of thyroid diseases plays a crucial role in modern endocrinology. Fine-needle aspiration biopsy (FNAB) offers high accuracy in verifying nodular formations, tumors, and autoimmune conditions, particularly in early stages. This article explores the methodology of specimen collection, cytomorphological criteria for evaluating cell samples, and the diagnostic value of this method in clinical decision-making.

background image

1649

ResearchBib IF - 11.01, ISSN: 3030-3753, Volume 2 Issue 5

CYTOLOGICAL DIAGNOSIS OF THYROID DISEASES: PRACTICAL

SIGNIFICANCE AND MODERN APPROACHES

Ergasheva Gulshan Tokhirovna

Assistant of the Department of Clinical Sciences Asian International University, Bukhara,

Uzbekistan

E-mail:

ergashevagulshantoxirovna@oxu.uz

https://doi.org/10.5281/zenodo.15536117

Abstract. Cytological diagnosis of thyroid diseases plays a crucial role in modern

endocrinology. Fine-needle aspiration biopsy (FNAB) offers high accuracy in verifying nodular
formations, tumors, and autoimmune conditions, particularly in early stages. This article
explores the methodology of specimen collection, cytomorphological criteria for evaluating cell
samples, and the diagnostic value of this method in clinical decision-making.

Keywords: thyroid gland, cytology, FNAB, thyroid nodules, autoimmune thyroiditis,

tumors.


Introduction
The cytological diagnosis of thyroid diseases has become an indispensable part of

modern endocrine pathology due to the increasing prevalence of thyroid nodules and
autoimmune conditions in the global population. The thyroid gland, being highly sensitive to
environmental, nutritional, and genetic factors, is prone to a wide range of disorders, including
goiter, thyroiditis, benign adenomas, and malignant tumors. Many of these pathologies present
with overlapping clinical symptoms, such as palpable nodules, hormonal imbalance, or
nonspecific systemic complaints, making clinical assessment alone insufficient for an accurate
diagnosis.

In this context, fine-needle aspiration biopsy (FNAB) has emerged as the gold standard

method for preoperative morphological evaluation of thyroid lesions. It is a minimally invasive,
cost-effective, and highly informative diagnostic procedure that allows the collection of cellular
material for cytological examination. FNAB provides critical insights into the nature of thyroid
nodules, differentiating between benign and malignant formations, and guiding the decision-
making process regarding the necessity and extent of surgical intervention.

While imaging techniques such as ultrasonography (US), scintigraphy, and elastography

play essential roles in detecting and characterizing thyroid lesions, they often fall short in
determining the exact cytological or histological nature of the pathology. For instance, cold
nodules on scintigraphy may or may not correspond to malignancy, and ultrasound features
alone cannot distinguish between follicular adenoma and carcinoma due to their similar
appearances. Therefore, microscopic evaluation of FNAB smears remains the definitive method
for morphological verification, especially in nodular thyroid disease.

Furthermore, the integration of FNAB results with clinical, biochemical, and radiological

data enhances diagnostic accuracy and allows for a more nuanced understanding of complex or
coexisting pathologies, such as autoimmune thyroiditis combined with nodular hyperplasia or
microcarcinoma. The importance of cytological diagnosis is especially evident in iodine-
deficient regions, where nodular goiter is endemic, and the need for differential diagnosis is
frequent.

Advancements in FNAB technique, including needle modifications and optimized smear

preparation methods, have significantly increased the quality and informativeness of collected


background image

1650

ResearchBib IF - 11.01, ISSN: 3030-3753, Volume 2 Issue 5

material. In expert hands, the accuracy of FNAB in diagnosing thyroid malignancies can reach
over 95%. However, challenges remain, particularly in cases of poorly cellular or bloody
aspirates, and in interpreting borderline cytological categories.

Given the growing demand for precision medicine and personalized treatment planning,

the role of thyroid cytology is expanding beyond initial diagnosis. It now contributes to
monitoring disease progression, evaluating therapeutic response, and stratifying patients for
surgical or conservative management. Consequently, cytologists, endocrinologists, and
pathologists must develop an integrated approach to interpreting FNAB results within the
broader clinical context.

This article aims to present a comprehensive overview of the methodology,

morphological criteria, and diagnostic value of FNAB in thyroid diseases, highlighting its role in
routine practice and its contribution to improving patient outcomes.

Methodology and FNAB Technique
Fine-needle aspiration biopsy of the thyroid is a minimally invasive method for extracting

material using a fine needle. Modified needles with notches, as practiced at the Endocrinology
Research Center (RAMS), improve sample collection and enable the acquisition of rich cellular
material even without aspiration. Prepared smears are stained using the May-Grünwald–Giemsa
technique and examined under a microscope.

The informativeness of the biopsy depends on the experience of the specialist and proper

targeting of the puncture site. Poor cellular samples often do not yield a conclusive diagnosis,
whereas rich smears allow for assessment of colloid composition, thyrocytes, proliferation signs,
inflammation, or atypia.

Diagnostic Criteria for Goiter Disease (Expanded)
Goiter disease, or thyroid enlargement, represents a heterogeneous group of pathologies

characterized by structural and functional changes in the thyroid gland. It may arise in response
to iodine deficiency, autoimmune reactions, or other environmental and genetic influences.
Cytologically, goiter is classified into three main morphological forms: diffuse, nodular, and
mixed (diffuse-nodular). Each form demonstrates specific features in fine-needle aspiration
biopsy (FNAB) smears that aid in establishing a reliable diagnosis and assessing disease activity.

1. Diffuse Goiter
Diffuse goiter is characterized by uniform enlargement of the thyroid gland without

discrete nodular formations. Cytological smears typically reveal:

Abundant dense colloid, often thick and viscous.

Scattered flattened or cuboidal thyrocytes, usually without significant atypia.

Low

cellularity

and

absence

of

architectural

complexity.

This type reflects colloid accumulation and gland hypertrophy in response to elevated
thyrotropin (TSH) levels, often due to iodine deficiency.

2. Nodular Goiter
Nodular goiter (also referred to as multinodular goiter or nodular hyperplasia) involves

the formation of one or more nodules within the thyroid tissue. These nodules may demonstrate
varying degrees of:

Follicular cell proliferation, sometimes forming microfollicular or papillary-like

structures.

Increased cellularity with small to moderately enlarged nuclei, occasional

binucleated cells, and mild anisocytosis.


background image

1651

ResearchBib IF - 11.01, ISSN: 3030-3753, Volume 2 Issue 5

The presence of regressive changes, such as:

o

Hemorrhage (with hemosiderin-laden macrophages or altered erythrocytes).

o

Cystic degeneration with proteinaceous or colloid fluid.

o

Fibrosis

and

hyalinization

of

nodule

stroma.

Cytological evaluation must differentiate between benign nodular hyperplasia and neoplastic
transformation, especially when cellular atypia or architectural complexity is present.

3. Mixed (Diffuse-Nodular) Goiter
This form combines features of both diffuse and nodular pathology. FNAB specimens

may demonstrate:

Heterogeneous background with colloid of varying consistency (dense, thin, or

finely granular).

A mixture of resting follicular cells and active proliferative zones, showing

microfollicular formations.

Possible coexistence of inflammatory infiltrates, particularly in cases with

superimposed

autoimmune

components.

This variant is commonly seen in patients with long-standing iodine deficiency or in those with
evolving autoimmune thyroid disease superimposed on a multinodular background.

4. Cytological Indicators of Proliferative Activity
In both nodular and mixed forms of goiter, the following features point toward active

follicular proliferation:

Increased number of follicular epithelial cells, often forming clusters,

microfollicles, or papillary-like projections.

Cells with enlarged, hyperchromatic nuclei, but lacking definitive features of

malignancy.

Absence of mitotic figures, which distinguishes hyperplastic from neoplastic

processes.

Occasional nuclear crowding or overlapping, especially in hyperfunctioning

nodules.

5. Importance of Colloid-Epithelial Balance
One of the key cytological criteria in diagnosing goiter is the ratio between colloid and

epithelial elements:

Predominantly colloid with sparse epithelial cells indicates colloid goiter.

Rich cellularity with minimal colloid suggests proliferative (hyperplastic) goiter.

Intermediate findings may reflect a transition or mixed state, requiring clinical

correlation and, occasionally, follow-up FNAB.

6. Clinical and Ultrasound Correlation
Since cytological features alone may not always reveal the full spectrum of changes,

especially in early or regressive stages, correlation with:

Ultrasound findings (nodule size, echogenicity, vascularity),

Hormonal assays (TSH, T3, T4 levels), and

Clinical

signs

(growth

pattern,

compressive

symptoms)

is essential for comprehensive diagnosis and management.

In conclusion, accurate cytological assessment of goiter depends not only on identifying

key cellular and colloidal features but also on understanding their biological context.
Recognizing the morphological spectrum of goiter enables differentiation from follicular


background image

1652

ResearchBib IF - 11.01, ISSN: 3030-3753, Volume 2 Issue 5

neoplasms and assists in guiding appropriate clinical follow-up or intervention.

Cytological Features of Autoimmune Processes
Autoimmune thyroiditis (AIT) is characterized by lymphocytes, plasma cells,

macrophages, and Askanazy (Hürthle) cells. Variants include classic (Hashimoto),
lymphomatous, and fibrotic forms. Graves’ disease shows abundant proliferating thyrocytes,
cytoplasmic vacuolization, hypertrophic nuclei, and absence of colloid. The presence of
peripheral blood in punctate reflects the gland's vascularity.

Benign and Malignant Neoplasms
Adenomas from A- and B-cells show varied structure (follicular, solid, papillary).

Cytologically, they display high cellularity, clear cell boundaries, basophilic cytoplasm, and
nuclear uniformity. Differentiation from nodular goiter is based on monomorphic proliferation.

Papillary carcinoma presents with nuclear grooves, pseudo-inclusions, and papillary

structures. Follicular carcinoma resembles adenoma; definitive diagnosis is histological.
Medullary carcinoma features granular cytoplasm, amyloid deposits, and metachromatic
staining.

The Bethesda Classification System
The modern Bethesda System for Reporting Thyroid Cytopathology (TBSRTC) includes

six categories ranging from "non-diagnostic" to "malignant." This standardized approach
improves communication between cytologists and clinicians and facilitates appropriate
management decisions.

Practical Importance of Cytology
Cytological assessment of thyroid punctates allows for:
avoiding unnecessary surgeries in benign cases;
identifying malignancies that require surgery;
monitoring nodular dynamics and treatment efficacy in AIT or Graves’ disease;
correlating findings with ultrasound and lab data for comprehensive evaluation
Conclusion
Cytological diagnosis of thyroid diseases is an essential tool in modern endocrinology. Its

success depends on quality sampling, precise FNAB technique, and expert microscopic
interpretation. Integrating cytology with clinical and imaging data enhances diagnostic accuracy
and optimizes patient management outcomes.

REFERENCES

1.

Брынова, О. В., Касоян, К. Т., Шабалова, И. П., Зима, А. П., Исаева, А. В., &

Саприна, Т. В. (2016). Метод жидкостной цитологии в диагностике заболеваний
щитовидной железы.

Клиническая лабораторная диагностика

,

61

(4), 225-228.

2.

Абенова, М. Т., Пикалова, Н. К., Жагапаров, М. К., Жумаканова, Ж. Т., &

Токушпекова, Л. Б. (2011). Цитологическая диагностика заболеваний щитовидной
железы.

Journal of Clinical Medicine of Kazakhstan

, (2 (21)), 144-146.

3.

Ergasheva, G. (2025). POLYCYSTIC OVARY SYNDROME: A COMPREHENSIVE

OVERVIEW AND CURRENT TREATMENT APPROACHES.

Modern Science and

Research

,

4

(4), 937-944.

4.

Narzulaeva, U. R., & Bekkulova, M. A. (2023). Arterial gipertenziya etiologiyasida

dislipidemiyaning xavf omili sifatidagi roli.

Science and Education

,

4

(2), 415-419.


background image

1653

ResearchBib IF - 11.01, ISSN: 3030-3753, Volume 2 Issue 5

5.

Ergasheva, G. (2025). ACROMEGALY: A SEVERE NEUROENDOCRINE

DISORDER WITH MULTISYSTEM MANIFESTATIONS.

Modern Science and

Research

,

4

(3), 1123-1131.

6.

Ergasheva, G. (2024). THE ROLE OF CORRECTIONAL PEDAGOGY IN

ORGANIZING THE EDUCATION OF CHILDREN WITH DISABILITIES.

Ethiopian

International Journal of Multidisciplinary Research

,

11

(06), 206-207.

7.

Zikrillaev, F. A. (2024). Cardiorehabilitations from Physiotherapeutic Treatments in

Cardiovascular Diseases.

American Journal of Bioscience and Clinical Integrity

,

1

(10),

96-102.

8.

Зикриллаев, Ф. А. (2024). ОПРЕДЕЛЕНИЕ РАННИХ ФАКТОРОВ РИСКА

ХРОНИЧЕСКОЙ БОЛЕЗНИ ПОЧЕК В ПУБЕРТНОМ ВОЗРАСТЕ.

Modern

education and development

,

16

(7), 166-180.

9.

Toxirovna, E. G. (2024). QALQONSIMON BEZ KASALLIKLARIDAN HASHIMOTO

TIREODIT KASALLIGINING MORFOFUNKSIONAL O’ZIGA XOSLIGI.

Modern

education and development

,

16

(7), 120-135.

10.

Toxirovna,

E.

G.

(2024).

REVMATOID

ARTRIT:

BO’G'IMLAR

YALLIG'LANISHINING SABABLARI, KLINIK BELGILARI, OQIBATLARI VA
ZAMONAVIY

DAVOLASH

YONDASHUVLARI.

Modern

education

and

development

,

16

(7), 136-148.

11.

Эргашева, Г. Т. (2024). ОЦЕНКА КЛИНИЧЕСКОЙ ЭФФЕКТИВНОСТИ

ОРЛИСТАТА

У

БОЛЬНЫХ

ОЖИРЕНИЕМ

И

АРТЕРИАЛЬНОЙ

ГИПЕРТЕНЗИЕЙ.

Modern education and development

,

16

(7), 92-105.

12.

Ergasheva, G. T. (2024). THE SPECIFICITY OFAUTOIMMUNE THYROIDITIS IN

PREGNANCY.

European Journal of Modern Medicine and Practice

,

4

(11), 448-453.

13.

Эргашева, Г. Т. (2024). ИССЛЕДОВАНИЕ ФУНКЦИИ ЩИТОВИДНОЙ ЖЕЛЕЗЫ

ПРИ ТИРЕОИДИТЕ ХАШИМОТО.

Modern education and development

,

16

(7), 106-

119.

14.

Toxirovna, E. G. (2024). GIPOFIZ ADENOMASINI NAZORAT QILISHDA

KONSERVATIV JARROHLIK VA RADIATSIYA TERAPIYASINING UZOQ
MUDDATLI SAMARADORLIGI.

Modern education and development

,

16

(7), 79-91.

15.

ERGASHEVA,

G.

T.

(2024).

OBESITY

AND

OVARIAN

INSUFFICIENCY.

Valeology: International Journal of Medical Anthropology and

Bioethics

,

2

(09), 106-111.

16.

Ergasheva, G. T. (2024). Modern Methods in the Diagnosis of Autoimmune

Thyroiditis.

American Journal of Bioscience and Clinical Integrity

,

1

(10), 43-50.

17.

Tokhirovna, E. G. (2024). COEXISTENCE OF CARDIOVASCULAR DISEASES IN

PATIENTS WITH TYPE 2 DIABETES.

TADQIQOTLAR. UZ

,

40

(3), 55-62.

18.

Toxirovna, E. G. (2024). DETERMINATION AND STUDY OF GLYCEMIA IN

PATIENTS WITH TYPE 2 DIABETES MELLITUS WITH COMORBID
DISEASES.

TADQIQOTLAR. UZ

,

40

(3), 71-77.

19.

Toxirovna, E. G. (2024). XOMILADORLIKDA QANDLI DIABET KELTIRIB

CHIQARUVCHI

XAVF

OMILLARINI

ERTA

ANIQLASH

USULLARI.

TADQIQOTLAR. UZ

,

40

(3), 63-70.


background image

1654

ResearchBib IF - 11.01, ISSN: 3030-3753, Volume 2 Issue 5

20.

Toxirovna, E. G. (2024). QANDLI DIABET 2-TIP VA KOMORBID KASALLIKLARI

BO’LGAN BEMORLARDA GLIKEMIK NAZORAT.

TADQIQOTLAR. UZ

,

40

(3), 48-

54.

21.

Tokhirovna, E. G. (2024). MECHANISM OF ACTION OF METFORMIN

(BIGUANIDE) IN TYPE 2 DIABETES.

JOURNAL OF HEALTHCARE AND LIFE-

SCIENCE RESEARCH

,

3

(5), 210-216.

22.

Tokhirovna, E. G. (2024). THE ROLE OF METFORMIN (GLIFORMIN) IN THE

TREATMENT OF PATIENTS WITH TYPE 2 DIABETES MELLITUS.

EUROPEAN

JOURNAL OF MODERN MEDICINE AND PRACTICE

,

4

(4), 171-177.

23.

Эргашева, Г. Т. (2024). Эффект Применения Бигуанида При Сахарным Диабетом 2

Типа И Covid-19.

Research Journal of Trauma and Disability Studies

,

3

(3), 55-61.

24.

Toxirovna, E. G. (2024). QANDLI DIABET 2 TUR VA YURAK QON TOMIR

KASALLIKLARINING BEMOLARDA BIRGALIKDA KECHISHI.

ОБРАЗОВАНИЕ

НАУКА И ИННОВАЦИОННЫЕ ИДЕИ В МИРЕ

,

38

(7), 202-209.

25.

Эргашева, Г. Т. (2024). СОСУЩЕСТВОВАНИЕ ДИАБЕТА 2 ТИПА И СЕРДЕЧНО-

СОСУДИСТЫХ ЗАБОЛЕВАНИЙ У ПАЦИЕНТОВ.

ОБРАЗОВАНИЕ НАУКА И

ИННОВАЦИОННЫЕ ИДЕИ В МИРЕ

,

38

(7), 219-226.

26.

Эргашева, Г. Т. (2024). СНИЖЕНИЕ РИСКА ОСЛОЖНЕНИЙ У БОЛЬНЫХ

САХАРНЫМ

ДИАБЕТОМ

2

ТИПА

И

СЕРДЕЧНО-СОСУДИСТЫМИ

ЗАБОЛЕВАНИЯМИ.

Образование Наука И Инновационные Идеи В Мире

,

38

(7),

210-218.

27.

Tokhirovna, E. G. (2024). CLINICAL AND MORPHOLOGICAL ASPECTS OF THE

COURSE

OF

ARTERIAL

HYPERTENSION.

Лучшие

интеллектуальные

исследования

,

12

(4), 234-243.

28.

Tokhirovna, E. G. Studying the Causes of the Relationship between Type 2 Diabetes and

Obesity.

Published in International Journal of Trend in Scientific Research and

Development (ijtsrd), ISSN

, 2456-6470.

29.

Toxirovna, E. G. (2024). ARTERIAL GIPERTENZIYA KURSINING KLINIK VA

MORFOLOGIK JIHATLARI.

Лучшие интеллектуальные исследования

,

12

(4), 244-

253.

30.

Эргашева, Г. Т. (2024). НОВЫЕ АСПЕКТЫ ТЕЧЕНИЕ АРТЕРИАЛЬНОЙ

ГИПЕРТОНИИ У ВЗРОСЛОГО НАСЕЛЕНИЕ.

Лучшие интеллектуальные

исследования

,

12

(4), 224-233.

31.

Эргашева, Г. Т. (2024). ФАКТОРЫ РИСКА РАЗВИТИЯ САХАРНОГО ДИАБЕТА 2

ТИПА.

ОБРАЗОВАНИЕ НАУКА И ИННОВАЦИОННЫЕ ИДЕИ В МИРЕ

,

36

(5), 70-

74.

32.

Эргашева, Г. Т. (2024). ОСЛОЖНЕНИЯ САХАРНОГО ДИАБЕТА 2 ТИПА

ХАРАКТЕРНЫ ДЛЯ КОГНИТИВНЫХ НАРУШЕНИЙ.

TADQIQOTLAR. UZ

,

30

(3),

112-119.

33.

Эргашева, Г. Т. (2023). Исследование Причин Связи Диабета 2 Типа И

Ожирения.

Research Journal of Trauma and Disability Studies

,

2

(12), 305-311.

34.

Tokhirovna, E. G. (2024). Risk factors for developing type 2 diabetes

mellitus.

ОБРАЗОВАНИЕ НАУКА И ИННОВАЦИОННЫЕ ИДЕИ В МИРЕ

,

36

(5),

64-69.


background image

1655

ResearchBib IF - 11.01, ISSN: 3030-3753, Volume 2 Issue 5

35.

Toxirovna, E. G. (2024). QANDLI DIABET 2-TUR VA O’LIMNI KELTIRIB

CHIQARUVCHI SABABLAR.

Лучшие интеллектуальные исследования

,

14

(4), 86-

93.

36.

Tokhirovna, E. G. (2023). Study of clinical characteristics of patients with type 2 diabetes

mellitus in middle and old age.

Journal of Science in Medicine and Life

,

1

(4), 16-19.

37.

Toxirovna, E. G. (2024). GIPERPROLAKTINEMIYA KLINIK BELGILARI VA

BEPUSHTLIKKA SABAB BO’LUVCHI OMILLAR.

Лучшие интеллектуальные

исследования

,

14

(4), 168-175.

38.

Toxirovna, E. G. (2023). QANDLI DIABET 2-TUR VA SEMIZLIKNING O’ZARO

BOG’LIQLIK

SABABLARINI

O’RGANISH.

Ta'lim

innovatsiyasi

va

integratsiyasi

,

10

(3), 168-173.

39.

Saidova, L. B., & Ergashev, G. T. (2022). Improvement of rehabilitation and

rehabilitation criteria for patients with type 2 diabetes.

40.

Эргашева, Г. Т. (2023). Изучение Клинических Особенностей Больных Сахарным

Диабетом 2 Типа Среднего И Пожилого Возраста.

Central Asian Journal of Medical

and Natural Science

,

4

(6), 274-276.

41.

Toxirovna, E. G. (2023). O’RTA VA KEKSA YOSHLI BEMORLARDA 2-TUR

QANDLI

DIABET

KECHISHINING

KLINIKO-MORFOLOGIK

XUSUSIYATLARI.

ОБРАЗОВАНИЕ НАУКА И ИННОВАЦИОННЫЕ ИДЕИ В

МИРЕ

,

33

(1), 164-166.

42.

Ergasheva, G. T. (2022). QANDLI DIABET BILAN KASALLANGANLARDA

REABILITATSIYA

MEZONLARINI

TAKOMILASHTIRISH.

TA'LIM

VA

RIVOJLANISH TAHLILI ONLAYN ILMIY JURNALI

,

2

(12), 335-337.

43.

Ergasheva, G. (2024). METHODS TO PREVENT SIDE EFFECTS OF DIABETES

MELLITUS IN SICK PATIENTS WITH TYPE 2 DIABETES.

Журнал академических

исследований нового Узбекистана

,

1

(2), 12-16.

44.

ГТ,

Э.,

&

Саидова,

Л.

Б.

(2022).

СОВЕРШЕНСТВОВАНИЕ

РЕАБИЛИТАЦИОННО-ВОССТАНОВИТЕЛЬНЫХ КРИТЕРИЕВ БОЛЬНЫХ С
СД-2 ТИПА.

TA'LIM VA RIVOJLANISH TAHLILI ONLAYN ILMIY JURNALI

,

2

(12),

206-209.

45.

Toxirovna, E. G. (2025). YURAK-QON TOMIR TIZIMI KASALLIKLARIDA

BEMORLAR PARVARISHINING O’ZIGA XOSLIGI.

Modern education and

development

,

20

(2), 38-46.

46.

Ergasheva,

G.

(2025).

PECULIARITIES

WHEN

ACCOMPANIED

BY

HYPOTHYROIDISM AND IODINE DEFICIENCY IN PATIENTS WITH ADRENAL
GLAND PATHOLOGY.

Modern Science and Research

,

4

(2), 1133-1140.

47.

Tokhirovna, E. G. (2024). Relationship of the Functional States of the Thyroid and the

Reproductive System in Women under Iodine Deficiency.

Journal of Science in Medicine

and Life

,

2

(6), 89-94.

48.

Зикриллаев, Ф. А. (2024). РОЛЬ ПРЕПАРАТОВ ЛЕРКАНИДИПИНА И

АМЛОДИПИНА В ЛЕЧЕНИИ АРТЕРИАЛЬНОЙ ГИПЕРТЕНЗИИ ПРИ
ХРОНИЧЕСКОЙ БОЛЕЗНИ ПОЧЕК.

Modern education and development

,

16

(7), 213-

229.


background image

1656

ResearchBib IF - 11.01, ISSN: 3030-3753, Volume 2 Issue 5

49.

Abdurashitovich, Z. F. (2024). DETERMINATION OF THE ETIOPATHOGENESIS

AND RISK FACTORS OF OBESITY AMONG ADOLESCENTS.

Modern education

and development

,

16

(7), 181-194.

50.

Abdurashitovich, Z. F. (2024). EARLY RISK FACTORS FOR ARTERIAL

HYPERTENSION AND FEATURES OF ITS ASSOCIATION WITH OTHER
DISEASES.

Modern education and development

,

16

(7), 195-212.


References

Брынова, О. В., Касоян, К. Т., Шабалова, И. П., Зима, А. П., Исаева, А. В., & Саприна, Т. В. (2016). Метод жидкостной цитологии в диагностике заболеваний щитовидной железы. Клиническая лабораторная диагностика, 61(4), 225-228.

Абенова, М. Т., Пикалова, Н. К., Жагапаров, М. К., Жумаканова, Ж. Т., & Токушпекова, Л. Б. (2011). Цитологическая диагностика заболеваний щитовидной железы. Journal of Clinical Medicine of Kazakhstan, (2 (21)), 144-146.

Ergasheva, G. (2025). POLYCYSTIC OVARY SYNDROME: A COMPREHENSIVE OVERVIEW AND CURRENT TREATMENT APPROACHES. Modern Science and Research, 4(4), 937-944.

Narzulaeva, U. R., & Bekkulova, M. A. (2023). Arterial gipertenziya etiologiyasida dislipidemiyaning xavf omili sifatidagi roli. Science and Education, 4(2), 415-419.

Ergasheva, G. (2025). ACROMEGALY: A SEVERE NEUROENDOCRINE DISORDER WITH MULTISYSTEM MANIFESTATIONS. Modern Science and Research, 4(3), 1123-1131.

Ergasheva, G. (2024). THE ROLE OF CORRECTIONAL PEDAGOGY IN ORGANIZING THE EDUCATION OF CHILDREN WITH DISABILITIES. Ethiopian International Journal of Multidisciplinary Research, 11(06), 206-207.

Zikrillaev, F. A. (2024). Cardiorehabilitations from Physiotherapeutic Treatments in Cardiovascular Diseases. American Journal of Bioscience and Clinical Integrity, 1(10), 96-102.

Зикриллаев, Ф. А. (2024). ОПРЕДЕЛЕНИЕ РАННИХ ФАКТОРОВ РИСКА ХРОНИЧЕСКОЙ БОЛЕЗНИ ПОЧЕК В ПУБЕРТНОМ ВОЗРАСТЕ. Modern education and development, 16(7), 166-180.

Toxirovna, E. G. (2024). QALQONSIMON BEZ KASALLIKLARIDAN HASHIMOTO TIREODIT KASALLIGINING MORFOFUNKSIONAL O’ZIGA XOSLIGI. Modern education and development, 16(7), 120-135.

Toxirovna, E. G. (2024). REVMATOID ARTRIT: BO’G'IMLAR YALLIG'LANISHINING SABABLARI, KLINIK BELGILARI, OQIBATLARI VA ZAMONAVIY DAVOLASH YONDASHUVLARI. Modern education and development, 16(7), 136-148.

Эргашева, Г. Т. (2024). ОЦЕНКА КЛИНИЧЕСКОЙ ЭФФЕКТИВНОСТИ ОРЛИСТАТА У БОЛЬНЫХ ОЖИРЕНИЕМ И АРТЕРИАЛЬНОЙ ГИПЕРТЕНЗИЕЙ. Modern education and development, 16(7), 92-105.

Ergasheva, G. T. (2024). THE SPECIFICITY OFAUTOIMMUNE THYROIDITIS IN PREGNANCY. European Journal of Modern Medicine and Practice, 4(11), 448-453.

Эргашева, Г. Т. (2024). ИССЛЕДОВАНИЕ ФУНКЦИИ ЩИТОВИДНОЙ ЖЕЛЕЗЫ ПРИ ТИРЕОИДИТЕ ХАШИМОТО. Modern education and development, 16(7), 106-119.

Toxirovna, E. G. (2024). GIPOFIZ ADENOMASINI NAZORAT QILISHDA KONSERVATIV JARROHLIK VA RADIATSIYA TERAPIYASINING UZOQ MUDDATLI SAMARADORLIGI. Modern education and development, 16(7), 79-91.

ERGASHEVA, G. T. (2024). OBESITY AND OVARIAN INSUFFICIENCY. Valeology: International Journal of Medical Anthropology and Bioethics, 2(09), 106-111.

Ergasheva, G. T. (2024). Modern Methods in the Diagnosis of Autoimmune Thyroiditis. American Journal of Bioscience and Clinical Integrity, 1(10), 43-50.

Tokhirovna, E. G. (2024). COEXISTENCE OF CARDIOVASCULAR DISEASES IN PATIENTS WITH TYPE 2 DIABETES. TADQIQOTLAR. UZ, 40(3), 55-62.

Toxirovna, E. G. (2024). DETERMINATION AND STUDY OF GLYCEMIA IN PATIENTS WITH TYPE 2 DIABETES MELLITUS WITH COMORBID DISEASES. TADQIQOTLAR. UZ, 40(3), 71-77.

Toxirovna, E. G. (2024). XOMILADORLIKDA QANDLI DIABET KELTIRIB CHIQARUVCHI XAVF OMILLARINI ERTA ANIQLASH USULLARI. TADQIQOTLAR. UZ, 40(3), 63-70.

Toxirovna, E. G. (2024). QANDLI DIABET 2-TIP VA KOMORBID KASALLIKLARI BO’LGAN BEMORLARDA GLIKEMIK NAZORAT. TADQIQOTLAR. UZ, 40(3), 48-54.

Tokhirovna, E. G. (2024). MECHANISM OF ACTION OF METFORMIN (BIGUANIDE) IN TYPE 2 DIABETES. JOURNAL OF HEALTHCARE AND LIFE-SCIENCE RESEARCH, 3(5), 210-216.

Tokhirovna, E. G. (2024). THE ROLE OF METFORMIN (GLIFORMIN) IN THE TREATMENT OF PATIENTS WITH TYPE 2 DIABETES MELLITUS. EUROPEAN JOURNAL OF MODERN MEDICINE AND PRACTICE, 4(4), 171-177.

Эргашева, Г. Т. (2024). Эффект Применения Бигуанида При Сахарным Диабетом 2 Типа И Covid-19. Research Journal of Trauma and Disability Studies, 3(3), 55-61.

Toxirovna, E. G. (2024). QANDLI DIABET 2 TUR VA YURAK QON TOMIR KASALLIKLARINING BEMOLARDA BIRGALIKDA KECHISHI. ОБРАЗОВАНИЕ НАУКА И ИННОВАЦИОННЫЕ ИДЕИ В МИРЕ, 38(7), 202-209.

Эргашева, Г. Т. (2024). СОСУЩЕСТВОВАНИЕ ДИАБЕТА 2 ТИПА И СЕРДЕЧНО-СОСУДИСТЫХ ЗАБОЛЕВАНИЙ У ПАЦИЕНТОВ. ОБРАЗОВАНИЕ НАУКА И ИННОВАЦИОННЫЕ ИДЕИ В МИРЕ, 38(7), 219-226.

Эргашева, Г. Т. (2024). СНИЖЕНИЕ РИСКА ОСЛОЖНЕНИЙ У БОЛЬНЫХ САХАРНЫМ ДИАБЕТОМ 2 ТИПА И СЕРДЕЧНО-СОСУДИСТЫМИ ЗАБОЛЕВАНИЯМИ. Образование Наука И Инновационные Идеи В Мире, 38(7), 210-218.

Tokhirovna, E. G. (2024). CLINICAL AND MORPHOLOGICAL ASPECTS OF THE COURSE OF ARTERIAL HYPERTENSION. Лучшие интеллектуальные исследования, 12(4), 234-243.

Tokhirovna, E. G. Studying the Causes of the Relationship between Type 2 Diabetes and Obesity. Published in International Journal of Trend in Scientific Research and Development (ijtsrd), ISSN, 2456-6470.

Toxirovna, E. G. (2024). ARTERIAL GIPERTENZIYA KURSINING KLINIK VA MORFOLOGIK JIHATLARI. Лучшие интеллектуальные исследования, 12(4), 244-253.

Эргашева, Г. Т. (2024). НОВЫЕ АСПЕКТЫ ТЕЧЕНИЕ АРТЕРИАЛЬНОЙ ГИПЕРТОНИИ У ВЗРОСЛОГО НАСЕЛЕНИЕ. Лучшие интеллектуальные исследования, 12(4), 224-233.

Эргашева, Г. Т. (2024). ФАКТОРЫ РИСКА РАЗВИТИЯ САХАРНОГО ДИАБЕТА 2 ТИПА. ОБРАЗОВАНИЕ НАУКА И ИННОВАЦИОННЫЕ ИДЕИ В МИРЕ, 36(5), 70-74.

Эргашева, Г. Т. (2024). ОСЛОЖНЕНИЯ САХАРНОГО ДИАБЕТА 2 ТИПА ХАРАКТЕРНЫ ДЛЯ КОГНИТИВНЫХ НАРУШЕНИЙ. TADQIQOTLAR. UZ, 30(3), 112-119.

Эргашева, Г. Т. (2023). Исследование Причин Связи Диабета 2 Типа И Ожирения. Research Journal of Trauma and Disability Studies, 2(12), 305-311.

Tokhirovna, E. G. (2024). Risk factors for developing type 2 diabetes mellitus. ОБРАЗОВАНИЕ НАУКА И ИННОВАЦИОННЫЕ ИДЕИ В МИРЕ, 36(5), 64-69.

Toxirovna, E. G. (2024). QANDLI DIABET 2-TUR VA O’LIMNI KELTIRIB CHIQARUVCHI SABABLAR. Лучшие интеллектуальные исследования, 14(4), 86-93.

Tokhirovna, E. G. (2023). Study of clinical characteristics of patients with type 2 diabetes mellitus in middle and old age. Journal of Science in Medicine and Life, 1(4), 16-19.

Toxirovna, E. G. (2024). GIPERPROLAKTINEMIYA KLINIK BELGILARI VA BEPUSHTLIKKA SABAB BO’LUVCHI OMILLAR. Лучшие интеллектуальные исследования, 14(4), 168-175.

Toxirovna, E. G. (2023). QANDLI DIABET 2-TUR VA SEMIZLIKNING O’ZARO BOG’LIQLIK SABABLARINI O’RGANISH. Ta'lim innovatsiyasi va integratsiyasi, 10(3), 168-173.

Saidova, L. B., & Ergashev, G. T. (2022). Improvement of rehabilitation and rehabilitation criteria for patients with type 2 diabetes.

Эргашева, Г. Т. (2023). Изучение Клинических Особенностей Больных Сахарным Диабетом 2 Типа Среднего И Пожилого Возраста. Central Asian Journal of Medical and Natural Science, 4(6), 274-276.

Toxirovna, E. G. (2023). O’RTA VA KEKSA YOSHLI BEMORLARDA 2-TUR QANDLI DIABET KECHISHINING KLINIKO-MORFOLOGIK XUSUSIYATLARI. ОБРАЗОВАНИЕ НАУКА И ИННОВАЦИОННЫЕ ИДЕИ В МИРЕ, 33(1), 164-166.

Ergasheva, G. T. (2022). QANDLI DIABET BILAN KASALLANGANLARDA REABILITATSIYA MEZONLARINI TAKOMILASHTIRISH. TA'LIM VA RIVOJLANISH TAHLILI ONLAYN ILMIY JURNALI, 2(12), 335-337.

Ergasheva, G. (2024). METHODS TO PREVENT SIDE EFFECTS OF DIABETES MELLITUS IN SICK PATIENTS WITH TYPE 2 DIABETES. Журнал академических исследований нового Узбекистана, 1(2), 12-16.

ГТ, Э., & Саидова, Л. Б. (2022). СОВЕРШЕНСТВОВАНИЕ РЕАБИЛИТАЦИОННО-ВОССТАНОВИТЕЛЬНЫХ КРИТЕРИЕВ БОЛЬНЫХ С СД-2 ТИПА. TA'LIM VA RIVOJLANISH TAHLILI ONLAYN ILMIY JURNALI, 2(12), 206-209.

Toxirovna, E. G. (2025). YURAK-QON TOMIR TIZIMI KASALLIKLARIDA BEMORLAR PARVARISHINING O’ZIGA XOSLIGI. Modern education and development, 20(2), 38-46.

Ergasheva, G. (2025). PECULIARITIES WHEN ACCOMPANIED BY HYPOTHYROIDISM AND IODINE DEFICIENCY IN PATIENTS WITH ADRENAL GLAND PATHOLOGY. Modern Science and Research, 4(2), 1133-1140.

Tokhirovna, E. G. (2024). Relationship of the Functional States of the Thyroid and the Reproductive System in Women under Iodine Deficiency. Journal of Science in Medicine and Life, 2(6), 89-94.

Зикриллаев, Ф. А. (2024). РОЛЬ ПРЕПАРАТОВ ЛЕРКАНИДИПИНА И АМЛОДИПИНА В ЛЕЧЕНИИ АРТЕРИАЛЬНОЙ ГИПЕРТЕНЗИИ ПРИ ХРОНИЧЕСКОЙ БОЛЕЗНИ ПОЧЕК. Modern education and development, 16(7), 213-229.

Abdurashitovich, Z. F. (2024). DETERMINATION OF THE ETIOPATHOGENESIS AND RISK FACTORS OF OBESITY AMONG ADOLESCENTS. Modern education and development, 16(7), 181-194.

Abdurashitovich, Z. F. (2024). EARLY RISK FACTORS FOR ARTERIAL HYPERTENSION AND FEATURES OF ITS ASSOCIATION WITH OTHER DISEASES. Modern education and development, 16(7), 195-212.